Kelvinson Fernandes Viana

Dr. Kelvinson Fernandes Viana

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Veterinary Parasitology
Verified
Journal Article
Closed access
RODOLFO CORDEIRO GIUNCHETTIRODOLFO CORDEIRO GIUNCHETTI
RODOLFO CORDEIRO GIUNCHETTI
PSPatricia Silveira
Patricia Silveira
LRLucilene Aparecida Resende
Lucilene Aparecida Resende
JLJaqueline Costa Leite
Jaqueline Costa Leite
OMOtoni Alves de Oliveira Melo-Júnior
Otoni Alves de Oliveira Melo-Júnior
ARAlexandre Barbosa Reis
Alexandre Barbosa Reis

1 April 2018 in Veterinary Parasitology
Verified
Journal Article
Closed access
KVKelvinson Fernandes Viana
Kelvinson Fernandes Viana
GLGiulia Lacerda
Giulia Lacerda
NTNatália Soares Teixeira
Natália Soares Teixeira
ACAlex Sander Rodrigues Cangussu
Alex Sander Rodrigues Cangussu
RARaimundo Wagner Sousa Aguiar
Raimundo Wagner Sousa Aguiar
RODOLFO CORDEIRO GIUNCHETTIRODOLFO CORDEIRO GIUNCHETTI
RODOLFO CORDEIRO GIUNCHETTI

19 January 2018 in Veterinary Research
Verified
Journal Article
Open access
PDF file
ACAlex Sander R Cangussu
Alex Sander R Cangussu
LMLuis André Mariuba
Luis André Mariuba
PLPritesh Lalwani
Pritesh Lalwani
KPKeila Dayane E. S. Pereira
Keila Dayane E. S. Pereira
SFSpartaco Astolfi Filho
Spartaco Astolfi Filho
PNPaulo Afonso Nogueira
Paulo Afonso Nogueira
Anaplasma marginale (A. marginale) has a remarkable impact on livestock production, and an effective vaccine is not currently available due to the inexistence of a small animal model. Recently, BALB/c mice were successfully infected with A. marginale, resulting in an acute and persistent anaplasmosis infection. Here, we designed a hybrid protein containing repeats of polypeptide 1a from major surface protein-1 complex (MSP1a) repeats and common epitopes of outer membrane proteins (OMPs) OMP7, OMP8 and OMP9 expressed in Escherichia coli. Our proof-of-concept assessed vaccinal effectiveness against a challenge with live bacteria. The MSP1a/OMP7/8/9 immunized BALB/C mice exhibited a strong reduction in rickettsemia and had no signs of anaplasmosis or hepatic lesions. In contrast, the non-immunized mice exhibited signs of anaplasmosis and a body weight loss associated with increases in monocyte and neutrophil counts. Furthermore, the non-immunized mice displayed atrophies with chronic inflammatory infiltrates in the spleen and increased binucleation and hydropic degeneration in the hepatocytes. Our findings demonstrated that immunization with our hybrid protein induced a strong reduction in rickettsemia and conferred protection against anaplasmosis. Therefore, given the strong evidence of the protective effect against anaplasmosis, hybrid protein designs are potential candidates for the rational design of vaccinal subunits.

26 October 2023 in Animals
Verified
Journal Article
Open access
PDF file
ARAçucena Veleh Rivas
Açucena Veleh Rivas
ASAngelo Gabriel Vidal dos Santos
Angelo Gabriel Vidal dos Santos
ASAdrieli Barboza de Souza
Adrieli Barboza de Souza
GJGilson Bueno Junior
Gilson Bueno Junior
GSGabriela Fernandes de Souza
Gabriela Fernandes de Souza
KVKelvinson Fernandes Viana
Kelvinson Fernandes Viana
One of the main factors limiting tilapia’s production is the occurrence of infections caused by Aeromonas and Streptococcus species. This work intended to evaluate a bivalent vaccine against A. hydrophila and S. agalactiae by intraperitoneal (i.p) administration in Nile tilapia (Oreochromis niloticus) in Brazil. The study was carried out in two phases: one in the laboratory, on a small scale, and from the results obtained, the study was expanded to a large scale in a production system in cages. The vaccine proved to be safe and effective in laboratory tests, with a vaccine efficacy (VE) of 93.66%. However, in large-scale tests with 12,000 tilapias, the VE was 59.14%, with a better food conversion ratio (1.54 kg) in the vaccinated group compared to the control group (1.27 kg). These results corroborate the efficiency of this tested vaccine; however, they indicate the need for field tests to attest to real protection.

3 January 2023 in Acta Tropica
Verified
Journal Article
Closed access
LCLuciana Chiyo
Luciana Chiyo
ASAngelo Gabriel dos Santos
Angelo Gabriel dos Santos
ASAdrieli Barboza de Souza
Adrieli Barboza de Souza
ARAçucena Veleh Rivas
Açucena Veleh Rivas
SVSofia Bernal Valle
Sofia Bernal Valle
KVKelvinson Fernandes Viana
Kelvinson Fernandes Viana

29 November 2022 in Plants
Verified
Journal Article
Open access
PDF file
JBJaqueline C. M. Borges
Jaqueline C. M. Borges
KHKhalid HADDI
Khalid HADDI
Wilson ValbonWilson Valbon
Wilson Valbon
LCLara Teixeira Melo Costa
Lara Teixeira Melo Costa
AAAscencio Ascencio
Ascencio Ascencio
Raimundo Wagner de Souza AguiarRaimundo Wagner de Souza Aguiar
Raimundo Wagner de Souza Aguiar
The use of formulations containing botanical products for controlling insects that vector human and animal diseases has increased in recent years. Plant extracts seem to offer fewer risks to the environment and to human health without reducing the application strategy’s efficacy when compared to synthetic and conventional insecticides and repellents. Here, we evaluated the potential of extracts obtained from caninana, Chiococca alba (L.) Hitchc. (Rubiaceae), plants as a tool to be integrated into the management of Aedes aegypti, one of the principal vectors for the transmission of arborviruses in humans. We assessed the larvicidal and repellence performance against adult mosquitoes and evaluated the potential undesired effects of the extracts on non-target organisms. We assessed the susceptibility and predatory abilities of the nymphs of Belostoma anurum, a naturally occurring mosquito larva predator, and evaluated the C. alba extract’s cytotoxic effects in mammalian cell lines. Our chromatographic analysis revealed 18 compounds, including rutin, naringin, myricetin, morin, and quercetin. The methanolic extracts of C. alba showed larvicidal (LC50 = 82 (72–94) mg/mL) activity without killing or affecting the abilities of B. anurum to prey upon mosquito larvae. Our in silico predictions revealed the molecular interactions between rutin and the AeagOBP1 receptor to be one possible mechanism for the repellent potential recorded for formulations containing C. alba extracts. Low cytotoxicity against mammalian cell lines reinforces the selectivity of C. alba extracts. Collectively, our findings highlight the potential of C. alba and one of its constituents (rutin) as alternative tools to be integrated into the management of A. aegypti mosquitoes.